Free Trial

Insider Selling: ReposiTrak Inc. (NYSE:TRAK) CEO Sells 3,500 Shares of Stock

ReposiTrak logo with Computer and Technology background

ReposiTrak Inc. (NYSE:TRAK - Get Free Report) CEO Randall K. Fields sold 3,500 shares of the stock in a transaction dated Wednesday, July 23rd. The stock was sold at an average price of $18.27, for a total value of $63,945.00. Following the transaction, the chief executive officer owned 132,000 shares of the company's stock, valued at approximately $2,411,640. The trade was a 2.58% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.

ReposiTrak Trading Up 1.8%

Shares of ReposiTrak stock traded up $0.32 during trading hours on Friday, reaching $18.39. 25,814 shares of the company's stock were exchanged, compared to its average volume of 61,961. The business's 50 day moving average is $20.21. ReposiTrak Inc. has a fifty-two week low of $15.72 and a fifty-two week high of $25.01. The company has a current ratio of 6.03, a quick ratio of 6.03 and a debt-to-equity ratio of 0.01. The firm has a market cap of $336.17 million, a PE ratio of 54.09 and a beta of 0.51.

ReposiTrak Cuts Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, August 14th. Stockholders of record on Monday, June 30th will be paid a dividend of $0.0182 per share. The ex-dividend date is Monday, June 30th. This represents a $0.07 dividend on an annualized basis and a dividend yield of 0.39%. ReposiTrak's dividend payout ratio is 20.59%.

Hedge Funds Weigh In On ReposiTrak

A hedge fund recently raised its stake in ReposiTrak stock. Ellsworth Advisors LLC boosted its position in ReposiTrak Inc. (NYSE:TRAK - Free Report) by 10.6% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 31,289 shares of the company's stock after purchasing an additional 2,997 shares during the period. Ellsworth Advisors LLC owned about 0.17% of ReposiTrak worth $634,000 as of its most recent filing with the SEC. 27.35% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Wall Street Zen upgraded ReposiTrak from a "hold" rating to a "buy" rating in a report on Thursday, May 22nd.

Check Out Our Latest Analysis on TRAK

ReposiTrak Company Profile

(Get Free Report)

Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.

Further Reading

Insider Buying and Selling by Quarter for ReposiTrak (NYSE:TRAK)

Should You Invest $1,000 in ReposiTrak Right Now?

Before you consider ReposiTrak, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ReposiTrak wasn't on the list.

While ReposiTrak currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Follow the Money: 5 Stocks Institutions Are Buying NOW
Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines